Anthony Squeglia
2010
In 2010, Anthony Squeglia earned a total compensation of $162.6K as Chief Financial Officer at Galectin Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Option Awards | $51,017 |
|---|---|
| Salary | $90,000 |
| Other | $21,606 |
| Total | $162,623 |
Squeglia received $90K in salary, accounting for 55% of the total pay in 2010.
Squeglia also received $51K in option awards and $21.6K in other compensation.
Rankings
In 2010, Anthony Squeglia's compensation ranked 10,044th out of 10,439 executives tracked by ExecPay. In other words, Squeglia earned more than 3.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,044 out of 10,439 | 4th |
Division Manufacturing | 3,705 out of 3,838 | 4th |
Major group Chemicals And Allied Products | 890 out of 921 | 3rd |
Industry group Drugs | 657 out of 680 | 3rd |
Industry Pharmaceutical Preparations | 465 out of 481 | 3rd |
Source: SEC filing on April 20, 2012.
Squeglia's colleagues
We found five more compensation records of executives who worked with Anthony Squeglia at Galectin Therapeutics in 2010.
2010
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
2010
Anatole Klyosov
Galectin Therapeutics
Chief Scientist
2010
Maureen Foley
Galectin Therapeutics
Chief Operating Officer
2010
David Platt
Galectin Therapeutics
Chief Executive Officer
2010
Eliezer Zomer
Galectin Therapeutics